882 results on '"Willis, Monte S."'
Search Results
2. The Role of Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Bone Microarchitecture In Vivo
3. Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
4. Fibrotic Signaling in Cardiomyopathies
5. New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis
6. The Unraveling: Cardiac and Musculoskeletal Defects and Their Role in Common Alzheimer Disease Morbidity and Mortality
7. The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo
8. Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover
9. Identification of Metabolic Changes in Ileum, Jejunum, Skeletal Muscle, Liver, and Lung in a Continuous I.V. Pseudomonas aeruginosa Model of Sepsis Using Nontargeted Metabolomics Analysis
10. Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans
11. The role of heat shock proteins and co-chaperones in heart failure
12. Sheehan, Harold Leeming (1900–1988)
13. Novel Cancer Therapies Targeting Angiogenesis
14. Post-analytical Issues in the Clinical Laboratory
15. Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo
16. Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all
17. Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease
18. The Genetic Basis and Molecular Diagnosis of Vascular Tumors and Developmental Malformations
19. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility
20. CHIP phosphorylation by protein kinase G enhances protein quality control and attenuates cardiac ischemic injury
21. Fibrotic Signaling in Cardiomyopathies
22. Genome-wide association study of homocysteine in African Americans from the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Coronary Artery Risk in Young Adults study
23. Low-Magnitude Mechanical Signals Combined with Zoledronic Acid Reduce Musculoskeletal Weakness and Adiposity in Estrogen-Deprived Mice
24. Ubiquitylation - Dependent Signaling in Heart Disease
25. Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling
26. BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo
27. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1
28. Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle–Specific Ubiquitin Ligase MuRF1
29. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis
30. Muscle RING finger-1 is required to prevent age-related cardiac hypertrophy and interstitial remodelling
31. The role of ubiquitin ligases in cardiac disease
32. SWI/SNF chromatin-remodeling complexes in cardiovascular development and disease
33. Acknowledgments
34. Preface
35. Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non‐targeted metabolomics analysis
36. Post-analytical Issues in the Clinical Laboratory
37. Novel Cancer Therapies Targeting Angiogenesis
38. Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice
39. Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction
40. Lung injury-induced skeletal muscle wasting in aged mice is linked to alterations in long chain fatty acid metabolism
41. Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo
42. Untargeted metabolomics analysis of ischemia–reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats
43. Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study
44. Ephrin–Eph signaling as a potential therapeutic target for the treatment of myocardial infarction
45. BMPER regulates cardiomyocyte size and vessel density in vivo
46. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease
47. Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis
48. Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes
49. The Role of Bone Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Microarchitecture In Vivo
50. Proteolysis in the Interstitial Space
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.